Assessment of treatment response in patients with glioblastoma using O-(2-18F-fluoroethyl)-L-tyrosine PET in comparison to MRI
The assessment of treatment response in glioblastoma is difficult with MRI because reactive
blood–brain barrier alterations with contrast enhancement can mimic tumor progression. In …
blood–brain barrier alterations with contrast enhancement can mimic tumor progression. In …
[PDF][PDF] Assessment of Treatment Response in Patients with Glioblastoma Using O-(2-18F-Fluoroethyl)-L-Tyrosine PET in Comparison to MRI
N Galldiks, KJ Langen, R Holy, M Pinkawa… - THE JOURNAL OF …, 2012 - Soc Nuclear Med
The assessment of treatment response in glioblastoma is difficult with MRI because reactive
blood–brain barrier alterations with contrast enhancement can mimic tumor progression. In …
blood–brain barrier alterations with contrast enhancement can mimic tumor progression. In …
Assessment of treatment response in patients with glioblastoma using O-(2-18F-fluoroethyl)-L-tyrosine PET in comparison to MRI
N Galldiks, KJ Langen, R Holy… - Journal of nuclear …, 2012 - pubmed.ncbi.nlm.nih.gov
The assessment of treatment response in glioblastoma is difficult with MRI because reactive
blood-brain barrier alterations with contrast enhancement can mimic tumor progression. In …
blood-brain barrier alterations with contrast enhancement can mimic tumor progression. In …
Assessment of Treatment Response in Patients with Glioblastoma Using O-(2-^ sup 18^ F-Fluoroethyl)-L-Tyrosine PET in Comparison to MRI
N Galldiks, KJ Langen, R Holy… - The Journal of …, 2012 - search.proquest.com
The assessment of treatment response in glioblastoma is difficult with MRI because reactive
blood-brain barrier alterations with contrast enhancement can mimic tumor progression. In …
blood-brain barrier alterations with contrast enhancement can mimic tumor progression. In …
[PDF][PDF] Assessment of Treatment Response in Patients with Glioblastoma Using O-(2-18F-Fluoroethyl)-L-Tyrosine PET in Comparison to MRI
N Galldiks, KJ Langen, R Holy… - THE JOURNAL OF …, 2012 - scholar.archive.org
The assessment of treatment response in glioblastoma is difficult with MRI because reactive
blood–brain barrier alterations with contrast enhancement can mimic tumor progression. In …
blood–brain barrier alterations with contrast enhancement can mimic tumor progression. In …
Assessment of treatment response in patients with glioblastoma using [18F] Fluoroethyl-L-Tyrosine PET in comparison to MRI
N Galldiks, KJ Langen, MD Piroth… - Journal of nuclear …, 2012 - juser.fz-juelich.de
The assessment of treatment response in glioblastoma is difficult with MRI because reactive
blood-brain barrier alterations with contrast enhancement can mimic tumor progression. In …
blood-brain barrier alterations with contrast enhancement can mimic tumor progression. In …
[引用][C] Assessment of Treatment Response in Patients with Glioblastoma Using O-(2-18F-Fluoroethyl)-l-Tyrosine PET in Comparison to MRI
N Galldiks, KJ Langen, R Holy, M Pinkawa… - Journal of Nuclear …, 2012 - cir.nii.ac.jp
Assessment of Treatment Response in Patients with Glioblastoma Using <i>O</i>-(2-<sup>18</sup>F-Fluoroethyl)-l-Tyrosine
PET in Comparison to MRI | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …
PET in Comparison to MRI | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …
Assessment of treatment response in patients with glioblastoma using O-(2-18F-fluoroethyl)-L-tyrosine PET in comparison to MRI.
N Galldiks, KJ Langen, R Holy, M Pinkawa… - Journal of Nuclear …, 2012 - europepmc.org
Methods In a prospective study, 25 patients with glioblastoma were investigated by MRI and
(18) F-FET PET after surgery (MRI-/FET-1), early (7-10 d) after completion of …
(18) F-FET PET after surgery (MRI-/FET-1), early (7-10 d) after completion of …
[PDF][PDF] Assessment of Treatment Response in Patients with Glioblastoma Using O-(2-18F-Fluoroethyl)-L-Tyrosine PET in Comparison to MRI
N Galldiks, KJ Langen, R Holy, M Pinkawa… - THE JOURNAL OF …, 2012 - Citeseer
The assessment of treatment response in glioblastoma is difficult with MRI because reactive
blood–brain barrier alterations with contrast enhancement can mimic tumor progression. In …
blood–brain barrier alterations with contrast enhancement can mimic tumor progression. In …
[PDF][PDF] Assessment of Treatment Response in Patients with Glioblastoma Using O-(2-18F-Fluoroethyl)-L-Tyrosine PET in Comparison to MRI
N Galldiks, KJ Langen, R Holy, M Pinkawa… - THE JOURNAL OF …, 2012 - researchgate.net
The assessment of treatment response in glioblastoma is difficult with MRI because reactive
blood–brain barrier alterations with contrast enhancement can mimic tumor progression. In …
blood–brain barrier alterations with contrast enhancement can mimic tumor progression. In …